Protein levels of HSD17B2 were in general significantly increased (p = 0.0236) in cancer as compared to adjacent control tissue with unchanged levels in 5 pairs, decreased levels in 11 pairs, and increased levels in 24 out of 40 pairs (Figures 7A,B, Supplementary Table 4). This evidence concerns the gene HSD17B2 and cancer.